CC3 – Structure-activity relationship

CC3. Structure–activity relationship describes the relationship between the structural characteristics of a drug and its binding site, and the resultant biological effect.

3.1. Structure–activity relationships form the basis of rational drug design.

3.2. Structure–activity relationships aim to predict potential targets from the molecular structure of the drug.

3.3. Structure–activity relationships can be manipulated during drug development processes to alter therapeutic and adverse effects.